InvestorsHub Logo

loanranger

09/16/22 10:10 PM

#393343 RE: williamssc #393341

Much is being made of this:
"Ongoing efforts are focused on dosing strategies for brilacidin to improve in vivo effectiveness in the form of a nasally-delivered countermeasure."

Aren't they just saying that they are trying to develop a way to put B up people's noses in the hope that it works better than the B they infused via people's bloodstreams worked?
They haven't put the stuff in the noses of any living things yet, have they?